Liminatus Pharma, Inc. (LIMN) Q3 2025 Earnings

Screener

Reported November 13, 2025 · Before market open

EPS-$0.07

Next report

Date not yet announced

Versus estimates

Diluted EPS

Q2 2026-$0.03 Q1 2026-$0.03 Q4 2025-$0.03

Q3 2025-$0.07

FAQ

When did Liminatus Pharma, Inc. report Q3 2025 earnings?: Liminatus Pharma, Inc. (LIMN) reported Q3 2025 earnings on November 13, 2025 before market open.
What were Liminatus Pharma, Inc.'s Q3 2025 revenue and EPS?: Liminatus Pharma, Inc. reported eps of $-0.07 for Q3 2025.
Where can I find Liminatus Pharma, Inc.'s Q3 2025 SEC filings?: You can read the 10-Q periodic report (0001104659-25-096872) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Liminatus Pharma, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk